Contact
MIT Startup Exchange actively promotes collaboration and partnerships between MIT-connected startups and industry. Qualified startups are those founded and/or led by MIT faculty, staff, or alumni, or are based on MIT-licensed technology. Industry participants are principally members of MIT’s Industrial Liaison Program (ILP).
MIT Startup Exchange maintains a propriety database of over 1,500 MIT-connected startups with roots across MIT departments, labs and centers; it hosts a robust schedule of startup workshops and showcases, and facilitates networking and introductions between startups and corporate executives.
STEX25 is a startup accelerator within MIT Startup Exchange, featuring 25 “industry ready” startups that have proven to be exceptional with early use cases, clients, demos, or partnerships, and are poised for significant growth. STEX25 startups receive promotion, travel, and advisory support, and are prioritized for meetings with ILP’s 230 member companies.
MIT Startup Exchange and ILP are integrated programs of MIT Corporate Relations.
Cagri Hakan Zaman Lecturer, MIT Department of Architecture
Assistant
Justin Solomon X-Consortium Career Development Associate Professor of Electrical Engineering and Computer Science
Alberto Rodriguez Walter Henry Gale (1929) Career Development Assistant Professor of Mechanical Engineering
Asuman Ozdaglar Joseph F. and Nancy P. Keithley, Professor of Electrical Engineering and Computer Science
Principal Investigator Dick Yue
In the last decade, the science of cell therapy and regenerative medicine has made remarkable progress. Work in this area has also resulted in numerous engineering successes, enabling sophisticated tools that open the door to new approaches for discovery and development of therapeutics. Particularly noteworthy is the recent progress in cell and molecular biology, including in stem cell research and gene editing. In this webinar, we will hear about new tools and the new directions they make possible as well as how each is being commercialized.
How can small molecules be identified that evoke cell or tissue regeneration by design? How can we engineer cells and tissue-growth in situ with a structure suitable for implantation? How can we physically gain access to the interior of cells for both discovery and engineering purposes? And how can the immune system be mapped with single-cell biology to accelerate discovery?